Search
Close this search box.

PreservaStem - Because all stem cells are not created equal.

PreservaStem cells were discovered by scientists working at Harvard. The unique cells are derived from the placenta at the time of birth, and are very potent, with the potential to differentiate into all 3 major tissue types that give rise to all organism the human body (mesoderm, endoderm, and ectoderm), vastly expanding their use for treating many different diseases. PreservaStem’s technology, based on several decades of scientific work, is able to not just store the placenta, but also has the patented technology needed to preserve these unique powerful cells.

PreservaStem’s stem cell banking service distinguishes itself by offering highly potent, versatile, and safely expandable stem cells derived from the placenta, supported by robust scientific evidence.

  • Scientific Validation: PreservaStem’s technology is backed by years of solid scientific evidence, ensuring its credibility, reliability, and exclusivity. This provides assurance to individuals considering stem cell storage that they are investing in a scientifically validated and patent protected technology.

  • Source of Stem Cells: PreservaStem is the ONLY birth tissue bank with patent protected technology that is able to preserve and isolate the highly multipotent cells present in the placenta which are more considered unique and much more versatile than other sources like cord blood or other birth tissues.

  • Versatile – to unlock regenerative potential: PreservaStem cells exhibit distinct characteristics, capable of differentiating into all three tissue types present (mesoderm, endoderm, and ectoderm), that lead to the development of all organs in the human body, thereby broadening the scope of medical treatments and augmenting their effectiveness in regenerative medicine.

  • Expansion Capacity: PreservaStem’s cells can be expanded to very large quantities, ensuring an abundant supply for potential treatments. This capability sets them apart from stem cells derived from other sources like cord, which have limitations in terms of expansion potential.

  • Safety Profile: One significant advantage of PreservaStem is their demonstrated safety profile, particularly in terms of tumor development. This is a crucial factor in the clinical application of stem cell therapies, as the risk of tumor formation can be a significant concern with certain stem cell types.

Cells potentially derived from PreservaStem’s placental stem cells

Mesoderm Cells Endoderm Cells Ectoderm Cells
Fat - YES Pancreas - YES Brain - YES
Muscle - YES Kidney - YES Spinal Cord - YES
Cartilage - YES Liver - YES Nerve - YES
Bone- YES Lung - YES Hair - YES
Thyroid - YES Tooth - YES
Parathyroid - YES Mouth - YES
Thymus - YES Skin - YES
Bladder - YES Nose - YES
Stomach - YES Ear - YES
Intestine - YES Eye - YES
Reproductive System - YES
Blood (hematopoietic) - YES
These factors collectively make PreservaStem a compelling option for individuals seeking to preserve their child’s stem cells for potential future medical treatments.

Cells potentially derived from Cord Blood

Mesoderm Cells Endoderm Cells Ectoderm Cells
Fat - No Pancreas - No Brain - No
Muscle - No Kidney - No Spinal Cord - No
Cartilage - No Liver - No Nerve - No
Bone- No Lung - No Hair - No
Thyroid - No Tooth - No
Parathyroid - No Mouth - No
Thymus - No Skin - No
Bladder - No Nose - No
Stomach - No Ear - No
Intestine - No Eye - No
Reproductive System - No
Blood (hematopoietic) - YES

As stated in the 2019 report by the American College of Obstetricians and Gynecologists,  “Routine storage of umbilical cord blood… as a form of ‘biological insurance’ against future disease… is not recommended by the American Academy of Pediatrics” given the lack of scientific data to support its use and availability of public cord blood banks; the American College of Obstetricians and Gynecologists concurs with this recommendation.

Private umbilical cord blood banking may be considered when there is knowledge of a family memberwith a medical condition (malignant or genetic) who could potentially benefit from cord blood transplantation.

Cells potentially derived from other birth tissues such as Wharton’s jelly, amniotic membrane and cord blood tissue

Mesoderm Cells Endoderm Cells Ectoderm Cells
Fat - YES Pancreas - No Brain - No
Muscle - YES Kidney - No Spinal Cord - No
Cartilage - YES Liver - No Nerve - No
Bone- YES Lung - No Hair - No
Thyroid - No Tooth - No
Parathyroid - No Mouth - No
Thymus - No Skin - No
Bladder - No Nose - No
Stomach - No Ear - No
Intestine - No Eye - No
Reproductive System - No
Blood (hematopoietic) - No
Other sources of birth tissues, such as Wharton’s Jelly, cord blood tissue, and amniotic membrane offer the ability to preserve mesenchymal stem cells (MSCs), which can give rise to fat, muscle, cartilage, and bone cells. The ability to grow these cells is very limited. Mesenchymal stem cells are also available any time during a person’s lifetime, by collecting them from various locations, such as fat or bone marrow.

Other stem cell sources that are not stored at the time of birth include:

  • Bone Marrow stem cells can be obtained any time during a person’s lifetime. There are two types of bone marrow: red and yellow. Red bone marrow contains Hematopoietic stem cells that can become blood cells. Hematopoietic stem cells can be used in a manner very similar to cord blood stem cells, mostly for blood cancers.

  • Hematopoietic stem cells are also found in the blood that is moving throughout your body. Yellow bone marrow is made mostly of fat and contains stem cells that can become fat, cartilage, or bone cells. The ability to grow and expand bone marrow stem cells is limited.

  • Embryonic Stem Cells(ES cells) are pluripotent stem cells derived from human embryos, meaning they can differentiate into all cell types of the body. However, ethical concerns have restricted their use, as has the risk of tumor formation.

  • Induced pluripotent stem cells (iPS cells), are pluripotent stem cells, created by reprogramming adult cells (like skin cells) to resemble embryonic stem cells in their capabilities. They can be expanded and differentiate into all cell types in the body. While IPS cells avoid ethical issues, they carry a risk of tumor formation